J Thorac Cardio- vasc Surg. 2017;154:1371 8.e1. CLINICAL STATEMENTS AND GUIDELINES 11. Taherkhani M, Hashemi SR, Hekmat M, et al. Thrombolytic therapy for right-sided mechanical pulmonic and tricuspid valves: the largest survival analysis to date. Tex Heart Inst J. 2015;42:543 7. 12. Kumar BM, Gnanaraj JP, Swaminathan N, et al. Assessment of hemody- namic and clinical response in thrombolytic therapy for prosthetic valve thrombosis. Indian Heart J. 2017;69:S6. 13. zkan M, G nd z S, G rsoy OM, et al. Ultraslow thrombolytic therapy: a novel strategy in the management of PROsthetic MEchanical valve Throm- bosis and the prEdictors of outcomE: the Ultra-slow PROMETEE trial. Am Heart J. 2015;170:409 18. 14. Roudaut R, Lafitte S, Roudaut M-F, et al. Fibrinolysis of mechanical pros- thetic valve thrombosis: a single-center study of 127 cases. J Am Coll Cardiol. 2003;41:653 8. 11.7. Bioprosthetic Valve Thrombosis 11.7.1. Diagnosis of Bioprosthetic Valve Thrombosis 1. Puri R, Auffret V, Rod s-Cabau J. Bioprosthetic valve thrombosis. J Am Coll Cardiol. 2017;69:2193 211. 2. Puvimanasinghe JP, Steyerberg EW, Takkenberg JJ, et al. Prognosis after aortic valve replacement with a bioprosthesis: predictions based on meta- analysis and microsimulation. Circulation. 2001;103:1535 41. 3. Dangas GD, Weitz JI, Giustino G, et al. Prosthetic heart valve thrombosis. J Am Coll Cardiol. 2016;68:2670 89. 4. Jose J, Sulimov DS, El-Mawardy M, et al. Clinical bioprosthetic heart valve thrombosis after transcatheter aortic valve replacement: inci- dence, characteristics, and treatment outcomes. JACC Cardiovasc Interv. 2017;10:686 97. 5. Chakravarty T, S ndergaard L, Friedman J, et al. Subclinical leaflet throm- bosis in surgical and transcatheter bioprosthetic aortic valves: an observa- tional study. Lancet. 2017;389:2383 92. 6. Pislaru SV, Hussain I, Pellikka PA, et al. Misconceptions, diagnostic chal- lenges and treatment opportunities in bioprosthetic valve thrombosis: les- sons from a case series. Eur J Cardiothorac Surg. 2015;47:725 32. 